House Of The Good Shepherd | |
798 Willow Grove Street, Hackettstown, New Jersey 07840 | |
(908) 684-5900 | |
Name | House Of The Good Shepherd |
---|---|
Location | 798 Willow Grove Street, Hackettstown, New Jersey |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 62 |
Occupancy Rate | 43.87% |
Medicare ID (CCN) | 315422 |
Legal Business Name | The House Of The Good Shepherd |
Ownership Type | Non Profit - Corporation |
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Mercy Medical Center has announced that Dwight D. Im, M.D., FACOG, Medical Director of The Neil B. Rosenshein, M.D., Institute for Gynecologic Care at Mercy, The Gynecologic Oncology Center at Mercy and The National Institute of Robotic Surgery at Mercy has been recognized by Castle Connolly Medical Ltd. as a "Top Doctor" for 2017.
The molecular switches regulating human cell growth do a great job of replacing cells that die during the course of a lifetime. But when they misfire, life-threatening cancers can occur. Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
A new study suggests that the presence of tumor cells in the circulating blood of patients with squamous cell cancer of the head and neck may predict disease recurrence and reduced survival.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 1 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 11.49 | 14.46 |
Percentage of long-stay residents who lose too much weight | 5.19 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 37.93 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.64 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 5.94 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 2.8 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 93.81 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 11.01 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 94.62 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 32.73 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.24 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 23.91 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.65 | 95.98 |
Percentage of short-stay residents who made improvements in function | 73.57 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 93.25 | 82.93 |
News Archive
Mercy Medical Center has announced that Dwight D. Im, M.D., FACOG, Medical Director of The Neil B. Rosenshein, M.D., Institute for Gynecologic Care at Mercy, The Gynecologic Oncology Center at Mercy and The National Institute of Robotic Surgery at Mercy has been recognized by Castle Connolly Medical Ltd. as a "Top Doctor" for 2017.
The molecular switches regulating human cell growth do a great job of replacing cells that die during the course of a lifetime. But when they misfire, life-threatening cancers can occur. Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
A new study suggests that the presence of tumor cells in the circulating blood of patients with squamous cell cancer of the head and neck may predict disease recurrence and reduced survival.
Janssen-Cilag International NV today announced that its next generation protease inhibitor (PI) OLYSIOTM (simeprevir) has been granted marketing authorisation by the European Commission (EC) for the treatment of adults with genotype 1 and 4 chronic hepatitis C (CHC), in combination with other medicinal products.
› Verified 1 days ago
Heath Village Location: 451 Schooley's Mountain Rd, Hackettstown, New Jersey 07840 Phone: (908) 852-4801 | |
House Of The Good Shepherd Location: 798 Willow Grove Street, Hackettstown, New Jersey 07840 Phone: (908) 684-5900 |